Bernard Ravina, Chief Medical Officer at Voyager Therapeutics, Inc. (VYGR), sold 21,960 shares at $20.33 ($446K) on 2017-10-10, disclosed to the SEC on 2017-10-12.
Open-market sale of $446k VYGR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.33 | 10,980 | $223K | 50.0% |
| 2 | $20.33 | 10,980 | $223K | 50.0% |
| Total | $20.33 avg | 21,960 | $446K | 100% |
| Filing → |
| VYGR | SELL | 2018-02-13 | $45K | — | Filing → |
| VYGR | SELL | 2018-01-12 | $119K | — | Filing → |
| VYGR | SELL | 2017-12-13 | $150K | — | Filing → |